FDA Inspection 1158368 — Organogenesis, Inc.
The FDA completed an inspection of Organogenesis, Inc. on December 1, 2021 in Canton, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 1, 2021
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Canton, MA (United States)